secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001213900-25-040727
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio dismisses Marcum as auditor, engages CBIZ CPAs due to acquisition
----------------------------------------------------------------------------

- Dismissed Marcum LLP on May 7, 2025, following acquisition of its attest business by CBIZ CPAs P.C.
- Audit committee approved engagement of CBIZ CPAs as new independent registered public accounting firm for fiscal 2025.
- No disagreements or reportable events during 2024, 2023, or through May 7, 2025.
- Prior audit report included going concern explanatory paragraph (substantial doubt about ability to continue as going concern).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025040727/0001213900-25-040727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025040727/ea0241210-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-040727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer